Skip to main content
. 2020 Jan 14;11(6):1568–1583. doi: 10.7150/jca.37637

Table 4.

Clinical and pathological characteristics of PTGDS high and PTGDS low group

Variables PTGDS high PTGDS low P-value
Number of cases 41 (40.8%) 57 (59.2%)
Age at diagnosis (years) 51.4 ± 7.8 52.5 ± 9.4 0.65
BMI (kg/m2) 23.12 ± 3.10 25.59 ± 4.25 0.01**
Breast-conserving surgery 18 (43.9%) 32 (56.1%) 0.32
ALD 10 (24.4%) 20 (35.1%) 0.36
Molecular subtype 0.04*
Luminal A 3 (7.3%) 4 (7.0%)
Luminal B 10 (24.4%) 26 (45.6%)
Her2 8 (19.5%) 14 (24.6%)
TNBC 20 (48.8%) 13 (22.8%)
Ki-67 0.37 0.39 0.88
T stage 0.04*
I 32 (78.0%) 32 (56.1%)
II-III 9 (22.0%) 25 (43.9%)
N stage 0.54
N0 33 (80.5%) 41 (71.9%)
N1-N3 8 (19.5%) 16 (28.1%)
Pathological stages 0.11
I 24 (58.5%) 24 (42.1%)
II 16 (39.0%) 26 (45.6%)
III 1 (2.4%) 7 (12.3%)
Histological grade 0.55
G1 2 (4.9%) 1 (1.8%)
G2 20 (48.8%) 33 (57.9%)
G3 19 (46.3%) 23 (40.3%)
Percentage of invasive tumor 0.86 ± 0.23 0.81 ± 0.17 0.44
TILs 0.34 ± 0.23 0.24 ± 0.18 0.12
PTGDS intensity 2.75 ± 0.44 1.34 ± 1.11 <0.0001***

CI, confidence interval; *P < 0.05, **P < 0.01, ***P < 0.001.